+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cutaneous model of invasive aspergillosis



Cutaneous model of invasive aspergillosis



Antimicrobial Agents and ChemoTherapy 54(5): 1848-1854



Cutaneous models have proven useful in studies of the pathogenesis and treatment of Gram-positive bacterial infections. Because cutaneous invasive aspergillosis (IA) occurs in the clinical setting, we sought to develop a nonlethal murine cutaneous model of IA. We induced cutaneous IA in cyclophosphamide-treated nude BALB/c mice by subcutaneous injection of Aspergillus fumigatus conidia. Skin lesion areas correlated well with tissue fungal burdens, allowing dynamic visual monitoring of cutaneous infections. The cutaneous model accurately reflected alterations in A. fumigatus pathogenicity resulting from deletions of recognized virulence genes (pabaA, sidA, and pksP). Moreover, analysis of the roles of conidial and mycelial catalases revealed that the former is required for the initiation of cutaneous aspergillosis, whereas the latter contributes to its propagation. Finally, posaconazole treatment reduced skin lesion areas relative to those of untreated and fluconazole-treated controls. This novel cutaneous model system should be applicable to comparative studies of the pathogenesis, treatment, and tissue specificity of IA.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052419214

Download citation: RISBibTeXText

PMID: 20145078

DOI: 10.1128/aac.01504-09


Related references

Cutaneous Invasive Aspergillosis: Retrospective Multicenter Study of the French Invasive-Aspergillosis Registry and Literature Review. Medicine 94(26): E1018, 2015

A nonlethal murine cutaneous model of invasive aspergillosis. Methods in Molecular Biology 845: 569-582, 2012

Primary cutaneous aspergillosis complicated with invasive aspergillosis in an extremely preterm infant: case report and literature review. Archives de Pediatrie 17(10): 1455-1459, 2010

Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Annals of Hematology 82(2): 80-82, 2003

Invasive pulmonary aspergillosis in a critically ill neonate: case report and review of invasive aspergillosis during the first 3 months of life. Clinical Infectious Diseases 27(3): 437-452, 1998

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with a History of Prior Invasive Aspergillosis Outcomes and Risks for Post-Transplant Invasive Aspergillosis. Blood 100(11): Abstract No 2463, 2002

Cutaneous Necrotic Papule as Invasive Aspergillosis in a Heart Transplant Patient. Skinmed 13(4): 329-330, 2016

Invasive cutaneous aspergillosis complicating immunosuppressive therapy for recalcitrant pemphigus vulgaris. Journal of the American Academy of Dermatology 38(3): 488-489, 1998

Disseminated invasive aspergillosis with cutaneous involvement in a patient with acute myeloblastic leukemia. Medicina Clinica 90(3): 116-118, 1988

A new model of invasive pulmonary aspergillosis in cyclosporin and methylprednisolone treated rabbits Comparison with a granulocytopenic model. Abstracts of the General Meeting of the American Society for Microbiology 93: 531, 1993

Cutaneous invasive aspergillosis in a patient with glioblastoma receiving long-term temozolomide and corticosteroid therapy. Journal of Infection and ChemoTherapy 23(4): 253-255, 2017

Value of an inhalational model of invasive aspergillosis. Medical Mycology 42(5): 417-425, 2004

Murine model of invasive aspergillosis. Methods in Molecular Medicine 118: 129-142, 2005

Invasive aspergillosis--a rabbit model. Malaysian Journal of Pathology 15(2): 119-123, 1993

Efficacy of PTX3 in a rat model of invasive aspergillosis. Antimicrobial Agents and ChemoTherapy 54(10): 4513-4515, 2010